PNC Financial Services Group
JBIO

PNC Financial Services Group’s Jade Biosciences JBIO Stock Holding History

PNC Financial Services Group’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.07K Sell
93
-2
-2% -$42 ﹤0.01% 4667
2026
Q1 		$1.33K Buy
95
+2
+2% +$29 ﹤0.01% 4689
2025
Q4 		$1.44K Buy
93
+10
+12% +$117 ﹤0.01% 4604
2025
Q3 		$716 Sell
83
-256
-76% -$2.09K ﹤0.01% 4745
2025
Q2 		$3.39K Sell
339
-60
-15% -$2.04K ﹤0.01% 4253
2025
Q1 		$35K Buy
399
+394
+7,880% +$34.6K ﹤0.01% 3283
2024
Q4 		$445 Buy
+5
New +$431 ﹤0.01% 4547
2024
Q3 		– Hold
0
– -$18 – 4785
2024
Q2 		– Hold
0
– – – 4741

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

PNC Financial Services Group's JBIO Position: Q2 2026 in Review

PNC Financial Services Group reduced its Jade Biosciences (JBIO) stake by 2.1% in Q2 2026, selling an estimated $42 and leaving 93 shares worth $2.07K. The position accounts for ﹤0.01% of the portfolio, ranked #4667.

PNC Financial Services Group first reported a position in JBIO in Q4 2024 and has held it in 7 quarters since. The position peaked at $35K in Q1 2025. 153 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • PNC Financial Services Group held 93 shares of Jade Biosciences worth $2.07K as of Q2 2026.
  • PNC Financial Services Group sold 2 Jade Biosciences shares in Q2 2026, an estimated $42.
  • Jade Biosciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4667 holding.
  • PNC Financial Services Group first reported a position in Jade Biosciences in Q4 2024 and has held it in 7 quarters since.
  • PNC Financial Services Group's Jade Biosciences position peaked at $35K in Q1 2025.
  • 153 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.